NASDAQ:XERS - Xeris Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$10.00 -0.12 (-1.19 %)
(As of 03/22/2019 04:00 PM ET)
Previous Close$10.00
Today's Range$9.92 - $10.30
52-Week Range$8.67 - $27.98
Volume158,759 shs
Average Volume451,474 shs
Market Capitalization$268.10 million
P/E Ratio-2.00
Dividend YieldN/A
BetaN/A

Analyst Ratings

Xeris Pharmaceuticals (NASDAQ:XERS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for Xeris Pharmaceuticals in the last 12 months. Their average twelve-month price target is $24.50, suggesting that the stock has a possible upside of 145.00%. The high price target for XERS is $27.00 and the low price target for XERS is $23.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $24.50$24.50$24.50$23.6667
Price Target Upside: 145.00% upside19.92% upside19.92% upside28.62% upside

Xeris Pharmaceuticals (NASDAQ:XERS) Consensus Price Target History

Price Target History for Xeris Pharmaceuticals (NASDAQ:XERS)

Xeris Pharmaceuticals (NASDAQ:XERS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/4/2018MizuhoReiterated RatingBuy$27.00MediumView Rating Details
7/16/2018Jefferies Financial GroupInitiated CoverageBuy$23.00HighView Rating Details
7/16/2018Royal Bank of CanadaInitiated CoverageOutperform$24.00HighView Rating Details
7/16/2018Leerink SwannInitiated CoverageOutperform$24.00HighView Rating Details
(Data available from 3/23/2017 forward)
This page was last updated on 3/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel